ID: ALA4585124

Max Phase: Preclinical

Molecular Formula: C70H109N17O12

Molecular Weight: 1380.75

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)N(C)C(=O)[C@H](N)CCCCN)C(C)C)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)O

Standard InChI:  InChI=1S/C70H109N17O12/c1-8-43(6)59(67(96)83-55(39-46-40-78-50-25-13-12-23-48(46)50)62(91)79-51(26-15-18-34-72)60(89)80-52(69(98)99)27-16-19-35-73)86-66(95)58(42(4)5)85-65(94)57(41(2)3)84-63(92)54(38-45-29-31-47(88)32-30-45)81-61(90)53(37-44-21-10-9-11-22-44)82-64(93)56(28-20-36-77-70(75)76)87(7)68(97)49(74)24-14-17-33-71/h9-13,21-23,25,29-32,40-43,49,51-59,78,88H,8,14-20,24,26-28,33-39,71-74H2,1-7H3,(H,79,91)(H,80,89)(H,81,90)(H,82,93)(H,83,96)(H,84,92)(H,85,94)(H,86,95)(H,98,99)(H4,75,76,77)/t43-,49+,51-,52+,53-,54-,55-,56-,57-,58-,59-/m0/s1

Standard InChI Key:  UPIDRVVFNIKDQA-KVPZATETSA-N

Associated Targets(Human)

Leukocyte surface antigen CD47 31 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

MEC1 72 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 1380.75Molecular Weight (Monoisotopic): 1379.8442AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Denèfle T, Pramil E, Gómez-Morales L, Levasseur MD, Lardé E, Newton C, Herry K, Herbi L, Lamotte Y, Odile E, Ancellin N, Grondin P, Martinez-Torres AC, Viviani F, Merle-Beral H, Lequin O, Susin SA, Karoyan P..  (2019)  Homotrimerization Approach in the Design of Thrombospondin-1 Mimetic Peptides with Improved Potency in Triggering Regulated Cell Death of Cancer Cells.,  62  (17): [PMID:31403795] [10.1021/acs.jmedchem.9b00024]

Source